Horiko Capital Management LLC Mckesson Corp Call Options Transaction History

Horiko Capital Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$437.42 - $470.64 $1.61 Million - $1.73 Million	3,672 Added 13114.29%	3,700 $1.71 Million
Q3 2023 Nov 13, 2023	BUY	$402.4 - $446.42 $11,267 - $12,499	28 New	28 $12,000
Q4 2022 Feb 14, 2023	SELL	$346.68 - $397.58 $8.49 Million - $9.74 Million	-24,488 Reduced 99.14%	212 $79,000
Q3 2022 Nov 14, 2022	SELL	$321.25 - $373.84 $1.12 Million - $1.31 Million	-3,500 Reduced 12.41%	24,700 $4.74 Million
Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $3.01 Million - $3.36 Million	-10,000 Reduced 26.18%	28,200 $5.03 Million
Q1 2022 May 16, 2022	SELL	$244.61 - $310.48 $1.25 Million - $1.58 Million	-5,100 Reduced 11.78%	38,200 $6.06 Million
Q4 2021 Feb 14, 2022	BUY	$198.21 - $248.9 $8.58 Million - $10.8 Million	43,300 New	43,300 $4.38 Million

1,706

111M

868K

903K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $88.1B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Horiko Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horiko Capital Management LLC with notifications on news.